Working at TrialSpark
The biggest bottleneck in bringing new treatments to patients is the clinical trial. On average, getting a drug through the trial process takes nearly a decade and frequently costs upward of $1 billion—and the problem is only getting worse.
TrialSpark is a new healthcare company that owns the end-to-end drug development process. Our proprietary technology allows us to integrate and improve clinical research for patients, providers, and sponsors, while executing clinical trials faster and cheaper.